
ABT-414 receives designation for the treatment of diffuse intrinsic pontine glioma (DIPG).

ABT-414 receives designation for the treatment of diffuse intrinsic pontine glioma (DIPG).

Recent advances and updates in oncology and cancer drug development.

Synjardy expanded to include treatment naïve adults with type 2 diabetes.

Optimal channel selection should be made with the patient’s best interest at the center of the decision.

New initiative supports several research collaborations to find a cure for HIV/AIDS.

Top news of the day from across the health care landscape.

Surveys show patients more willing to seek more aggressive treatment than physicians realize.

An award of $55 million will help launch different infrastructure needed to improve precision medicine.

Study sheds light on HIV development.

Surgery combined with chemotherapy and radiation may be a good option for pancreatic cancer patients whose tumors involved blood vessels.

Chimeric antigen receptor T cell therapy targets advanced forms of leukemia and lymphoma.

Making the jump from retail to specialty pharmacy.

Specialty pharmacists play an important role in making evidence-based recommendations for the treatment of hepatitis C virus.

Care coordination with case management now found to improve HIV viral suppression in hospitalized patients.

Some tumors can remain undetected from current cancer treatments.

Orencia ClickJect Autoinjector has an ergonomic design that may be beneficial for patients.

A new study’s findings contradict previous assumptions about IVF and breast cancer risk.

Top news of the day from across the health care landscape.

Gross total resection is difficult to achieve due to complexities involved with brain cancer.

Is the cost of specialty drugs worth the price in small patient populations?

Phase 2 clinical trial of brentuximab vedotin (Adcetris) monotherapy in relapsed or refractory classical Hodgkin lymphoma treatment shows improved survival.

Maternal antiretroviral therapy decreases the threat of HIV transmission through breast milk.

Obinutuzumab not found to improve progression-free survival in untreated diffuse large B-cell lymphoma.

Surprising findings on the relationship between obesity, type 2 diabetes, and dementia.

Notch signaling pathway found to drive prostate cancer metastasis.

Top news of the day from across the health care landscape.

Intracellular receptor protects against the negative effects of inflammation in ALS.

Patients treated with HCV drugs prior to transplant found to have higher overall post-transplant care costs.

Self-reported prevalence of prostate cancer found lower in men who take aspirin.

Four genes found linked to epigenetic mechanisms that contribute to multiple sclerosis.